In the wake of the coronavirus pandemic, many older adults are more socially isolated than ever—and thus more vulnerable to being financially victimized.
When Sunshine Retirement Living officials saw a significant drop in the use of antipsychotics in its memory care residents after piloting a “sensory spa” in one community, its mission became clear. The company expanded use of the spas throughout its portfolio.
Patients with dementia and memory issues could soon have a new way to connect. Cue Teddy is a teddy bear that not only talks but listens.
Medicare officials have decided that the federal health insurance program should only cover the controversial new Alzheimer’s drug Aduhelm for patients who are participating in approved clinical trials. The preliminary decision, reached after lengthy deliberations, was released on Tuesday by the Center for Medicare and Medicaid Services, or C.M.S. If it is finalized later this year, it would significantly limit the number of patients who could use the expensive drug.
Scientists from Osaka City University are reporting successful preclinical tests of a novel nasal spray designed to prevent the neurodegeneration associated with dementia. The spray combines two inexpensive, pre-existing drugs and was found to improve cognitive function in several different mouse models of dementia.